| 000 | 01801 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515162446.0 | ||
| 264 | 0 | _c20090729 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1432-0428 | ||
| 024 | 7 |
_a10.1007/s00125-009-1308-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLutgers, H L | |
| 245 | 0 | 0 |
_aSkin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. _h[electronic resource] |
| 260 |
_bDiabetologia _cMay 2009 |
||
| 300 |
_a789-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aArm _xradiation effects |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescence |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 |
_aGlycation End Products, Advanced _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLight |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPhysicians, Family |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aSkin _xradiation effects |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aGerrits, E G | |
| 700 | 1 | _aGraaff, R | |
| 700 | 1 | _aLinks, T P | |
| 700 | 1 | _aSluiter, W J | |
| 700 | 1 | _aGans, R O | |
| 700 | 1 | _aBilo, H J | |
| 700 | 1 | _aSmit, A J | |
| 773 | 0 |
_tDiabetologia _gvol. 52 _gno. 5 _gp. 789-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-009-1308-9 _zAvailable from publisher's website |
| 999 |
_c18714323 _d18714323 |
||